Ananiti-malaria drug touted by President Trump as a"game changer" for COVID-19 showed no benefit, according to an analysis of patients hospitalized in Veterans Health Administration medical centers.
The analysis found the two primary outcomes for people treated with hydroxychloroquine were death and the need for mechanical ventilation.
The analysis was conducted retrospectively, based on data from patients hospitalized with confirmed COVID-19 infections in all VA medical centers until April 11, 2020.
TVNL Comment: Read the second paragraph carefully. Self-anointed Dr. Trump is a charleton.
Boeing’s public relations crisis is now out of this world: the company’s Starliner spacecraft with two...
Wisconsin Attorney General Josh Kaul has filed felony forgery charges against an aide and two attorneys...
More than 50,000 people have died prematurely in California over a decade due to exposure to...
As much as we would all love to ignore COVID, a new set of variants that...
